We defined two groups of AML samples using patients with highest gene expression values of ACSS1 (n = 10) and highest gene expression values of ACSS2 (n = 10) denoted as top ACSS1/2 samples (n = 20). Here, ACSS1 is linked to acute myeloid leukemia.